Pernix Therapeutics acquires antibiotic Cedax
Pernix Therapeutics Holdings Inc. said that it has acquired the antibiotic Cedax from Shionogi Pharma Inc. for $6.1 million.
CeNeRx BioPharma, a drug development company with deep-pocketed backers, has raised $15 million to test whether its most advanced experimental medicine, an antidepressant called Tyrima, works in patients.